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Introduction
</NOHTML>The activation of natural killer (NK) cells, which is mediated by 
the recognition of their ligands by activation receptors, triggers 
a complex, highly regulated response leading to the death of a 
target cell. Cytolytic responses require reorganization of the 
  actin cytoskeleton for receptor translocation at the cell surface 
to facilitate conjugate formation, initiation, the continuation of 
signaling, and effective killing (Carpen et al., 1983; Vyas et al., 
2002). This dynamic and highly complex process is regulated 
by a variety of actin-binding proteins, such as cofi  lin, profi  lin, 
and Wiskott-Aldrich syndrome protein (WASp), as well as Scar 
family proteins, thymosins, capping proteins, and the Arp2/3 
complex (dos Remedios et al., 2003; Pollard and Borisy, 2003). 
The latter is crucial for actin nucleation and formation of new 
actin fi  lament branches (Higgs and Pollard, 2001). The Arp2/3 
complex, which is formed from seven subunits (Robinson et al., 
2001; Volkmann et al., 2001), is closely regulated by WASp 
family proteins (Higgs and Pollard, 2001). WASp binds to the 
Arp2/3 complex (Machesky and Insall, 1998), increasing its af-
fi  nity for ATP (Le Clainche et al., 2001). WASp activity, in turn, 
is tightly controlled by a variety of adaptor and regulatory 
  proteins (Orange et al., 2004), including the WASp-interacting 
protein (WIP; Ramesh et al., 1997).
NK cells are very useful for studying the regulation of cyto-
toxic cell activity because of the expression of the killer cell 
 immunoglobulin-like receptors (KIR; Vilches and Parham, 2002) 
that are capable of inhibition of NK cell cytotoxicity (Long, 
1999). A characteristic feature of inhibitory KIR molecules is a 
long cytoplasmic tail (76–95 amino acids) containing one or two 
immunoreceptor tyrosine-based inhibition motifs (ITIMs; Vely 
et al., 1996). Upon tyrosine phosphorylation, inhibitory KIR 
ITIMs serve as docking sites for the protein tyrosine   phosphatases 
SHP-1 and -2 (Campbell et al., 1996; Olcese et al., 1996), which 
can dephosphorylate kinases and adaptor proteins that are in-
volved in early events of signal transduction (Blery et al., 2000), 
leading to inhibition of NK cell activity. The number of proteins 
that are dephosphorylated is presently unknown.
In this study, we describe a multiprotein complex com-
prised of WIP, WASp, actin, and myosin IIA that is formed dur-
ing NK cell activation, but is not formed in the presence of 
KIR2DL1 inhibitory signaling. The identifi  cation of this multi-
molecular protein complex that is regulated by activating and 
inhibitory signaling provides insight into understanding the 
  cytoskeletal rearrangements and mechanisms essential for NK 
cytolytic activity.
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T
he tumor natural killer (NK) cell line YTS was used 
to examine the cytoskeletal rearrangements required 
for cytolysis. A multiprotein complex weighing 
 1.3 mD and consisting of WASp-interacting protein 
(WIP), Wiskott-Aldrich syndrome protein (WASp), actin, 
and myosin IIA that formed during NK cell activation was 
identiﬁ  ed. After induction of an inhibitory signal, the 
  recruitment of actin and myosin IIA to a constitutive WIP–
WASp complex was greatly decreased. Both actin and 
myosin IIA were recruited to WIP in the absence of WASp. 
This recruitment correlated with increased WIP phosphor-
ylation, which was mediated by PKCθ. Furthermore, the 
disruption of WIP expression by WIP RNA interference 
prevented the formation of this protein complex and led 
to almost complete inhibition of cytotoxic activity. Thus, 
the multiprotein complex is important for NK cell function, 
killer cell immunoglobulin-like receptor inhibitory signal-
ing affects proteins involved in cytoskeletal rearrange-
ments, and WIP plays a central role in the formation of the 
complex and in the regulation of NK cell activity.
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Figure 1.  A multiprotein complex formed during NK cell activation is altered by inhibitory signaling. (A) YTS/KIR2DL1/FLAG-WIP cells were mixed with 
721.221 or 721.221/Cw6 cells, immediately transferred to 37°C, and incubated for the indicated times. Cell lysates were immunoprecipitated with anti-
FLAG mAb. Immunoprecipitated proteins were resolved on a 4–12% NuPage gel and stained with silver. The proteins recruited to the complex (marked by 
numbered asterisks) were subsequently analyzed by MS. (B) An example of vacuum matrix–assisted laser disorption ionization MS analysis of the band 
corresponding to the ﬁ  rst asterisk (*1) in the silver-stained gel in A. The lettered peaks obtained were identiﬁ  ed as matching myosin IIA heavy chain and 
are overlaid on a schematic of the 1,960–amino acid residue molecule (bottom). The width of the individual box is representative of the size of the given 
peptide. Boxes shown in dark gray were further positively identiﬁ   ed by MS peptide sequence. (C) Western blotting analysis of the anti-FLAG–
  immunoprecipitated proteins shown in A. The same PVDF membrane was sequentially stripped and probed with anti–myosin IIA, anti-FLAG, anti-WASp, 
anti-actin, and anti–myosin light chain antibodies. The molecular masses of the proteins according to their position, relative to molecular mass markers, are 
shown in parentheses. (D) A KIR2DL1 mutant, lacking the ITIM motifs, is unable to affect the formation of the complex. YTS/KIR2DL1*250/FLAG-WIP cells 
were mixed with 721.221/Cw6 cells, immediately transferred to 37°C, and incubated for the indicated times. Cell lysates were immunoprecipitated with 
anti-FLAG mAb. Immunoprecipitated proteins were visualized by immunoblotting with anti–myosin IIA, anti-FLAG, anti-WASp, anti-actin, and anti–myosin 
regulatory light chain antibodies. (E) Effects of actin inhibitors on the interaction of WIP and actin. YTS/KIR2DL1/FLAG-WIP cells were pretreated with 
DMSO (controls) or with the following actin inhibitors: latrunculin A (LatA), latrunculin B (LatB), jasplakinolide (Jasp), or swinholide A (SwA) at the indicated 
concentrations for 30 min at 37°C, followed by mixing with 721.221 target cells (except for the negative control) for 10 min at 37°C. Cell lysates were 
  immunoprecipitated with anti-FLAG mAb and immunoblotted with anti-FLAG and anti-actin antibodies. pos. contr., cells pretreated with 0.1% DMSO and 
activated by mixing with 721.221 target cells (positive control); neg. contr., resting cells treated with 0.1% DMSO (negative control).
Results
Formation of a multiprotein complex 
during NK cell activation
Cytolytic reactions are dependent on cytoskeletal proteins, but 
the orchestration of rearrangements of the cytoskeletal elements 
that is required for cytolysis is unclear. Physiologically contrast-
ing activating and inhibitory signaling in NK cells were used to 
highlight important stages in control of cytoskeletal function. 
The inhibitory model was that of the YTS NK tumor cell line, 
into which the inhibitory receptor KIR2DL1 had been intro-
duced (YTS/KIR2DL1), and a major histocompatibility class I
(MHCI)–negative B lymphoblastoid 721.221 cell in which the 
KIR2DL1 ligand HLA-Cw6 had been expressed (721.221/Cw6).
The activating paradigm was the cytolytic interaction be-
tween YTS/KIR2DL1 cells and 721.221 cells. NK cells, 
although   expressing an inhibitory receptor, lyse class I MHC 
protein–negative targets. YTS/KIR2DL1 cells stably express-
ing FLAG-WIP (YTS/KIR2DL1/FLAG-WIP) were generated 
to defi  ne the cytoskeletal complex in cytolytic and noncytolytic 
interactions and to investigate whether WIP and/or WASp are 
targeted by KIR2DL1 inhibitory signaling.
First, YTS/KIR2DL1/FLAG-WIP cells were activated by 
mixing with the appropriate target cells. Immunoprecipitation MULTIPROTEIN COMPLEX IN NK CELLS • KRZEWSKI ET AL. 123
with anti-FLAG mAb revealed a substantial number of proteins 
that coimmunoprecipitated with FLAG-WIP (Fig. 1 A).  [ID]FIG1[/ID]Specifi  c 
components of this complex (marked by asterisks in Fig. 1 A) 
were identifi  ed by tandem mass spectrometry (MS). The pres-
ence of WIP and WASp in the complex was confi  rmed, and the 
additional presence of actin, myosin IIA heavy chain, and two 
myosin light chains was revealed (Table I).  [ID]TBL1[/ID] An example is shown 
for myosin IIA identifi  cation in Fig. 1 B. The presence of these 
proteins was subsequently verifi   ed by immunoblotting (Fig. 
1  C). Because WIP has been shown to interact with WASp 
  (Ramesh et al., 1997), and actin has been demonstrated to bind 
both WIP (Martinez-Quiles et al., 2001) and WASp (Miki and 
Takenawa, 1998), the presence of WASp and actin in the complex 
was not surprising. However, the inducible recruitment of actin 
and the constitutive presence of WASp in the complex are 
noteworthy. The presence of both heavy and light chains of myosin 
IIA (Fig. 1, A [left] and C) indicates their probable involvement in 
cytotoxic NK cell activity. An interaction between WIP and a 
  myosin in mammalian cells has not been previously reported.
Treatment of cells with latrunculin A and B, which bind to 
monomeric actin and prevent its polymerization (Spector et al., 
1999), eliminated actin binding to WIP in a dose-dependent 
manner (Fig. 1 E), as well as myosin IIA binding (unpublished 
data); therefore, the complex could not be formed. However, 
  either stabilization of actin fi  laments by jasplakinolide or treat-
ment of cells with swinholide A, which has fi  lament-severing 
ability (Spector et al., 1999), both resulted in increased actin 
binding to WIP (Fig. 1 E). Thus, the actin found in the complex 
appears to be F-actin. The WIP–WASp interaction was stable 
under all conditions.
The multiprotein complex formed 
during NK cell activation is >1 mD
The results implied that activation of NK cells might trigger 
formation of a large oligomeric structure. To test this, the rela-
tive elution positions of WIP and WASp in gel fi  ltration chro-
matography in resting and activated YTS/KIR2DL1/FLAG-
WIP cells were investigated.
In resting NK cells, FLAG-WIP and the majority of WASp 
were eluted with the partition coeffi  cient Kav = 0.43 (Fig. 2 A), 
corresponding to a mass of  350–400 kD on the calibration 
curve.  [ID]FIG2[/ID] WIP and WASp migrated on SDS-PAGE as proteins of 
60 and 62 kD, respectively. The presence of WIP and WASp in the 
relatively high mass fraction may refl  ect either their interaction 
with other proteins in the cell or oligomerization. Importantly, 
Figure 2.  The multiprotein complex formed during NK cell activation is  1,300 kD. YTS/KIR2DL1/FLAG-WIP cells alone or mixed with 721.221 target 
cells for 10 min at 37°C were lysed, and lysates were applied to the Superose 6 column. Proteins from fractions were resolved on a NuPage gel, transferred 
to PVDF membrane, and sequentially immunoblotted for the presence of actin, myosin IIA, WASp, and FLAG-WIP to identify the main components of the 
complex (only relevant fractions are shown). The molecular masses of the proteins according to their position, relative to molecular masses markers, are 
shown in parentheses. Kav values for proteins of interest were calculated based on elution volumes and ﬁ  tted to a calibration curve to estimate the size of 
complexes. (A) In nonstimulated NK cells, WIP and WASp exist as a part of a complex of  350–400 kD, and neither myosin IIA nor actin are present in 
the fractions containing WIP and WASp. (B) After NK cell stimulation, WIP and WASp, along with actin and myosin IIA, become part of a multimeric 
  complex with a mass of  1,200–1,300 kD.
Table I. Main components of the multiprotein complex
Number Name Calculated 
molecular mass
Accession number
kD
1 Myosin IIA 226.5 P35579
2 WIP 51.5 O43516
3 WASp 52.9 P42768
4 Actin 42 P62736
5 Myosin light chain 2 19.7 P19105
6 Myosin light chain 3 16.9 P60660
A summary of the main components of the multiprotein complex, which were 
identiﬁ   ed by tandem MS, along with their calculated molecular masses and 
  accession numbers (available from GenBank/EMBL/DDBJ). The order numbers 
in the table correspond to the asterisk numbers shown in Fig. 1 A.JCB • VOLUME 173 • NUMBER 1 • 2006  124
neither myosin IIA nor actin was found in the fractions contain-
ing WIP and WASp, demonstrating that the complex was not 
formed in resting cells. However, the activation of NK cells re-
sulted in the shift of the majority of WIP and WASp to a frac-
tion, with the partition coeffi  cient Kav = 0.3, corresponding to a 
mass of  1,200–1,500 kD (Fig. 2 B). Moreover, the change of 
WIP–WASp position was accompanied by the simultaneous ap-
pearance of myosin IIA and actin in the same fraction, indicat-
ing that a multiprotein complex of  1,300 kD was formed after 
NK cell activation.
The majority of actin in both resting and activated cells, 
likely representing the monomeric actin pool, was eluted 
with Kav = 0.61 (Fig. 2), which is the same Kav as that of the 
molecular mass standard ovalbumin (43 kD), thus validating 
the measurements.
KIR2DL1 signaling affects 
complex formation
To evaluate the function of inhibitory receptor KIR2DL1 in 
YTS cells conjugated with physiological target cells, phosphor-
ylation of the receptor was investigated. First, phosphorylation 
of KIR2DL1 that had previously been transduced into YTS cells 
(Cohen et al., 1999) after antibody cross-linking was deter-
mined over time. Maximum KIR2DL1 phosphorylation in YTS 
cells was found at 3 min (Fig. 3), in agreement with a previous 
study (Faure et al., 2003) showing maximum phosphorylation 
of KIR at 3.5 min after ligand binding on the surface of insect 
cells.  [ID]FIG3[/ID] Induction of KIR2DL1 phosphorylation was specifi  c be-
cause irrelevant antibody did not induce KIR phosphorylation. 
Importantly, a signaling-defi  cient KIR2DL1*250 mutant lack-
ing both ITIMs (Fassett et al., 2001) was not phosphorylated. 
Interestingly, KIR2DL1 migrated on the gel as a doublet after 
induction, likely because of differential phosphorylation of the 
two ITIMs in KIR2DL1 because at time 0 unphosphorylated 
KIR2DL1 migrated as a single band. Similarly, KIR2DL1*250 
migrated as a single nonphosphorylated band (Fig. 3).
Next, the effect of inhibitory signaling in YTS/KIR2DL1/
FLAG-WIP cells was examined using 721.221/Cw6 cells as the 
target, as HLA-Cw6 is a ligand for KIR2DL1 (Colonna et al., 
1993). Complex formation was strongly diminished in the pres-
ence of KIR2DL1-mediated signaling (Fig. 1, A [right] and C). 
Specifi  cally, actin was recruited to the complex after 3 min 
of NK cell activation, with maximum phosphorylation at 10 
min, and its amount decreased with time. In contrast, inhibi-
tory signaling largely prevented the appearance of actin in the 
complex. Association of myosin IIA with the WIP–WASp com-
plex increased substantially by 10 min after NK cell activa-
tion and correlated with the appearance of myosin regulatory 
light chain and actin. An increased amount of myosin IIA was 
observed, even at 60 min. In contrast, NK cell inhibition only 
resulted in a slight increase in the amount of myosin IIA and its 
association with the WIP-based complex was quickly disrupted. 
Thus, KIR2DL1 inhibitory signaling effected the interaction of 
myosin IIA with the complex, similarly to actin. Interestingly, 
WASp that is present in FLAG-WIP immunoprecipitates was 
not affected by inhibitory signaling.
To test if the observed effects were KIR2DL1 mediated, 
the YTS/KIR2DL1*250 cell line that is defi  cient in KIR signal-
ing was used. The binding of KIR2DL1*250 to its ligand had no 
effect on complex formation (Fig. 1 D), and the resulting com-
plex was identical to that found in activated YTS/KIR2DL1 
cells. Thus, KIR2DL1*250 was unable to infl  uence complex 
formation, demonstrating that the KIR inhibitory receptor sig-
nal affects complex assembly and/or function of the multipro-
tein complex created during NK cell activation.
WIP, WASp, and myosin IIA polarize 
to the cell–cell contact site with F-actin 
after NK cell activation
Formation of the complex and its alteration by inhibitory sig-
naling raised the question of whether or not the complex is 
a part of the immune synapse. Therefore, we examined the 
  localization of the complex in the cell after activation or 
  inhibition. In resting YTS/KIR2DL1/FLAG-WIP cells, nearly 
all FLAG-WIP colocalized with WASp, but not all WASp colo-
calized with FLAG-WIP, likely refl  ecting a pool of WASp either 
bound to endogenous WIP or not associated with WIP (Fig. 4 A). 
[ID]FIG4[/ID]Importantly, both proteins were dispersed throughout the   cyto-
plasm, whereas myosin IIA (as well as F-actin; Fig. S1, available
at http://www.jcb.org/cgi/content/full/jcb.200509076/DC1)
was located at the cell periphery. The activation of NK cells 
by mixing with target cells resulted in the relocation of FLAG-
WIP and WASp and the accumulation of myosin IIA at the 
cell–cell contact site (Fig. 4 A), where F-actin was also local-
ized (Fig. S1; Orange et al., 2003). FLAG-WIP was polarized 
toward the contact site in 76% of conjugates of NK cells with 
susceptible target cells, and 16% of it was found at the syn-
apse. Similarly, WASp was polarized in 64% of cytolytic conju-
gates, with 22% found at the cell–cell interface. The remainder 
Figure 3.  KIR2DL1 phosphorylation. YTS cells alone or transfected with 
KIR2DL1 or KIR2DL1*250 (Fassett et al., 2001) were incubated for the in-
dicated times at 37°C with protein G beads coated with anti-KIR2DL1 mAb 
or control IgG (cIgG; YTS/KIR2DL1 cells only). Immunoprecipitated mate-
rial was immunoblotted with anti-KIR2DL1 polyclonal antibodies (top) or 
anti-phosphotyrosine mAb (bottom). The double band present in both im-
ages likely represents two forms of KIR2DL1, differentially phosphorylated 
on ITIMs. The KIR2DL1*250 mutant migrates faster through the gel be-
cause of its smaller size and mass, and it is not phosphorylated. YTS cells 
were used as an additional negative control.MULTIPROTEIN COMPLEX IN NK CELLS • KRZEWSKI ET AL. 125
of the WIP–WASp complex polarized to a region adjacent to 
the synapse. Myosin IIA accumulated at the contact site in 
60% of conjugates (Fig. 4 B) and colocalized with FLAG-WIP 
(Fig. 4 A). F-actin also accumulated at the cell–cell interface 
in 85% of cytolytic conjugates (Fig. S1), in agreement with a 
previous study (Orange et al., 2003). Strikingly, in conjugates 
formed between NK cells and nonsusceptible 721.221/Cw6 cells 
(that initiated inhibitory signaling in YTS/KIR2DL1/FLAG-
WIP cells) neither FLAG-WIP, WASp, myosin IIA, nor F-actin 
polarized toward the cell–cell contact site (Fig. 4 B and Fig. S1),
and the distribution of those proteins remained as it was in 
  resting cells (Fig. 4 A). Thus, in response to NK cell activation, 
WIP, WASp, and myosin IIA moved to the cell–cell contact site 
with F-actin, whereas KIR2DL1 inhibitory signaling prevented 
that relocalization.
Recruitment of actin and myosin IIA 
is independent of WASp
The constitutive presence of a WIP–WASp complex, which 
is unaffected by inhibitory signaling (Fig. 1 C), raised 
the question of whether recruitment of actin and myosin IIA 
to the complex is mediated by WIP or by WASp. To test this, 
the YTS/KIR2DL1 cells were transfected with a WIP COOH-
terminal deletion mutant, FLAG-WIP∆460–503, which excluded 
the region required for WASp binding (amino acid residues 
461–485 of WIP; Volkman et al., 2002) and should prevent 
WASp from binding to WIP. Analysis of anti-FLAG immuno-
pre  cipitates from activated YTS/KIR2DL1/FLAG-WIP∆460–503
cells   revealed that WASp was not pulled down by the mu-
tant FLAG-WIP∆460–503 protein. However, this mutant still 
  allowed recruitment of actin and myosin IIA to the complex 
(Fig. 5). Recruitment of actin, but not myosin IIA heavy chain, to 
the complex was decreased in activated YTS/KIR2DL1/FLAG-
WIP∆460–503 cells, suggesting that WASp may contribute to 
actin recruitment or deletion of the COOH-terminal part of WIP 
and may cause changes in WIP conformation affecting actin 
binding. Nevertheless, actin and myosin IIA interaction with 
the complex appears to be independent of WASp and to require 
functional WIP.
WIP phosphorylation is affected 
by NK cell signaling
To assess possible mechanisms governing the control of genera-
tion of the multiprotein complex, phosphorylation of the com-
plex components was examined. Because WIP, but not WASp, 
seemed to play an essential role in complex formation (Fig. 5), 
WIP phosphorylation in response to NK cell signaling was in-
vestigated, with particular focus on whether the phosphoryla-
tion of WIP could affect interaction of the components of the 
complex with WIP.
WIP has been shown to undergo phosphorylation in T cells 
in response to CD3ζ chain cross-linking (Sasahara et al., 2002). 
Because WIP has been demonstrated to inhibit WASp activity 
in vitro (Martinez-Quiles et al., 2001), it has been proposed that 
WIP phosphorylation allows WASp to dissociate form WIP, 
releasing WASp from WIP inhibition (Sasahara et al., 2002). 
Figure 4.  WIP, WASp, and myosin IIA polarize 
to cell–cell contact site after NK cell activation, 
but not after inhibition. YTS/KIR2DL1/FLAG-
WIP cells, unconjugated or conjugated by 
mixing for 10 min at 37°C with target cells 
(either 721.221 [cytolytic interaction] or 
721.221/Cw6 [noncytolytic interaction]), 
were stained with anti-WASp mAb followed by 
Alexa Fluor 647–conjugated goat anti–mouse 
(green), anti–myosin IIA followed by Alexa 
Fluor 405–conjugated goat anti–rabbit (blue), 
and Cy3-conjugated anti-FLAG mAb (red). NK 
cells were identiﬁ  ed by GFP ﬂ  uorescence and 
anti-FLAG staining. (A) Images of FLAG-WIP, 
WASp, and myosin IIA localization in resting 
cells (top), cytolytic (middle), and noncytolytic 
(bottom) conjugates. (B) The percentages of 
FLAG-WIP, WASp, and myosin IIA polarization 
toward cell–cell contact site in cytolytic (left) or 
noncytolytic (right) conjugates. Percentages of 
proteins polarized and found at the contact 
site (total polarization), or proteins found ex-
clusively at the cell–cell contact site (synaptic 
accumulation), and percentages of proteins 
not polarized to the contact site (no polariza-
tion) ± SD are shown. The values were deter-
mined by evaluation of 150–200 conjugates 
in 3–4 separate experiments. n   200 for WIP 
and WASp; n   150 for myosin IIA.JCB • VOLUME 173 • NUMBER 1 • 2006  126
To evaluate this paradigm in NK cells the YTS/KIR2DL1/
FLAG-WIP cells were labeled with [
32P]orthophosphate and 
WIP phosphorylation status was analyzed after the activation 
and inhibition of NK cells with appropriate target cells.
After the activation or inhibition of NK cells, anti-FLAG 
immunoprecipitation demonstrated two distinct bands of 
phosphoproteins, which were identifi  ed as WIP and WASp by 
immunoblotting (Fig. 6 A). WIP was phosphorylated even at 
time 0, suggesting that WIP is constitutively phosphorylated 
in NK cells. WIP phosphorylation quickly increased upon NK 
cell activation to twofold after 3 min, reached a maximum 
of 2.7-fold at 10 min, and decreased to the basal level at 60 min 
(Fig. 6 B). On the contrary, inhibition of NK cell activity by 
KIR2DL1 signaling resulted in no increase of WIP phosphor-
ylation, indicating that KIR2DL1 inhibitory signaling infl  u-
enced WIP phosphorylation. Surprisingly, phosphorylation 
of WASp pulled down by FLAG-WIP did not change signifi  -
cantly during activation or inhibition of NK cells (unpub-
lished data), but it is likely that small WASp phosphorylation 
changes could have been undetected because of its constitutive 
phosphorylation at S483 and S484 (Cory et al., 2003). Most 
interestingly, changes in WIP phosphorylation states did not 
affect WASp binding, as defi  ned by coimmunoprecipitation 
studies, indicating that the function of WIP phosphorylation 
during NK cell activation may be different than the regulation 
of WIP–WASp association.
Thus, the WIP phosphorylation level changes in response 
to NK cell signaling. WIP may be phosphorylated at several dif-
ferent sites, as judged by the increase of WIP phosphorylation, 
in addition to the basal level of phosphorylation. Increase and 
inhibition of WIP phosphorylation by activation and inhibitory 
signaling, respectively, suggests that WIP phosphorylation may 
be important for proper WIP function.
WIP phosphorylation in NK cells 
is mediated by PKC𝗉
WIP was indirectly shown to be phosphorylated by PKCθ in 
T cells (Sasahara et al., 2002). Because WIP phosphorylation 
was not required for regulation of the WIP–WASp interaction, 
the possible function of WIP phosphorylation and the identifi  -
cation of the kinase responsible for WIP phosphorylation in 
NK cells were examined next.
Analysis of the WIP amino acid sequence revealed sev-
eral consensus sites for PKC- and casein kinase II–mediated 
phosphorylation. Consequently, the effects of PKC and CKII 
inhibitors were studied. To test if PKC family kinases are in-
volved, a general inhibitor of PKC activity, bisindolylmaleimide I, 
was used, as well as PKCα,β and PKCθ pseudosubstrates, 
which specifi  cally inhibit activity of α, β, and θ isoenzymes, 
respectively. Pretreatment with bisindolylmaleimide I, followed 
by activation of YTS/KIR2DL1/FLAG-WIP cells, resulted in 
severely decreased WIP phosphorylation compared with con-
trol, indicating that a PKC family kinase is involved in WIP 
phosphorylation (Fig. 6 C). Pretreatment of cells with PKCα,β 
pseudosubstrate (Fig. 6 C) or with Gö6983, which inhibits PKC 
α, β, γ, δ, and ζ (80 nM; unpublished data), did not decrease 
WIP phosphorylation after NK cell activation, suggesting that 
these isoenzymes were not involved in WIP phosphorylation. 
Similarly, treatment with specifi  c CKII inhibitor did not affect 
the WIP phosphorylation state, indicating that casein kinase II is 
not involved in WIP phosphorylation in vivo. However, pre-
treatment with the pseudosubstrate inhibitor specifi  c for PKCθ 
prevented WIP phosphorylation after NK cell stimulation (Fig. 
6 C), demonstrating that PKCθ is responsible for phosphoryla-
tion of WIP in NK cells.
WIP phosphorylation is correlated 
with multiprotein complex formation
Because WIP phosphorylation was affected by activation and 
inhibitory signaling (Fig. 6), and the changes in WIP phosphor-
ylation levels over time appeared to be related to recruitment of 
actin and myosin IIA to the complex, the relationship between 
the WIP phosphorylation state and the formation of the multi-
protein complex was investigated.
In addition to PKC inhibitors, the YTS/KIR2DL1/FLAG-
WIP cells were treated with protein tyrosine kinase inhibitors. 
Myosin inhibitors were also used to assess the effect of myosin 
activity inhibition on complex formation. Pretreatment of cells 
before activation with an Src family kinase inhibitor, PP2, did 
not affect WIP phosphorylation or the recruitment of actin and 
myosin IIA to the complex, indicating that complex formation 
is not regulated by Src family kinases (Fig. 6 C). A decrease 
of actin and myosin IIA binding was seen after treatment with 
100 μM of the general protein tyrosine kinase inhibitor genistein 
Figure 5.  Actin and myosin IIA interaction with WIP is independent of WASp. YTS/KIR2DL1 cells were transfected with FLAG-WIP or FLAG-WIP∆460-503, 
which is a mutant protein lacking the WASp binding domain. Transfected cells were mixed with 721.221 cells and incubated for the indicated times at 
37°C. Cell lysates were immunoprecipitated with anti-FLAG mAb. Immunoprecipitated proteins were immunoblotted with anti–myosin IIA, anti-FLAG, anti-
WASp, or anti-actin antibodies. The molecular masses of the proteins according to their position relative to molecular mass markers are shown in parentheses. 
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(unpublished data), but the observed effects were most likely non-
specifi  c because of the inhibition of all tyrosine kinases and an 
impairment of NK cell functions. Inhibition of myosin IIA heavy 
chain or regulatory light chain activity with blebbistatin or ML-7, 
respectively, before NK cell activation did not disrupt complex 
formation. However, inhibition of PKC activity abolished both 
actin and myosin IIA, but not WASp, recruitment. The disruption 
of complex formation was caused only by specifi  c inhibition of 
the θ and not the α, β (Fig. 6 C), γ, δ, or ζ (unpublished data) iso-
forms. Hence, PKCθ activity is crucial for WIP phosphorylation. 
The results suggest that actin and myosin IIA recruitment and 
proper complex formation during NK cell activation correlate 
with WIP phosphorylation and are likely dependent on it.
Chemical inhibitors of PKC activity blocked NK cell 
cytotoxicity (unpublished data). However, the analysis of the 
effects of PKC inhibitors in regard to the multiprotein complex 
involvement in NK cell cytotoxicity is extremely complicated 
because the long-term effects of PKC inhibitors, as opposed to 
the short-term effects, are very broad, infl  uencing many intra-
cellular pathways.
Effects of WIP and WASp RNAi
Changes in WIP phosphorylation during NK cell activation that 
correlate with complex formation, combined with the obser-
vation that the WIP–WASp interaction is independent of the 
WIP phosphorylation state (Fig. 6), implicate WIP in functions 
Figure 6.  WIP phosphorylation increases upon NK cell 
activation and is mediated by PKC𝗉. (A) 
32P-labeled YTS/
KIR2DL1/FLAG-WIP cells were mixed with target cells, 
  either 721.221 or 721.221/Cw6, transferred to 37°C, 
and incubated for the indicated times. Cell lysates were 
immunoprecipitated with anti-FLAG mAb. Immunoprecipi-
tated proteins were visualized by autoradiography and 
then immunoblotted with anti-FLAG antibody, followed by 
anti-WASp to visualize WIP and WASp, respectively. 
(B) Quantitation of WIP phosphorylation showing increase 
of WIP phosphorylation with maximum at 10 min of NK 
cell activation. The increase in phosphorylation of WIP 
was assessed by densitometry, which was normalized to 
phosphorylation observed at time 0 min and expressed as 
arbitrary units. (C) 
32P-labeled cells were pretreated with 
0.1% DMSO (control) or with the following kinase inhibi-
tors: bisindolylmaleimide I (Bisi.), PKCα and PKCβ pseu-
dosubstrate inhibitor (αβ
inh), PKCθ pseudosubstrate 
inhibitor (θ
inh), casein kinase II inhibitor (CK2
inh), Src fam-
ily kinase inhibitor (PP2), blebbistatin (BL), or ML-7 at the 
indicated concentrations for 30 min at 37°C, followed by 
mixing with 721.221 cells for 10 min at 37°C. Cell ly-
sates were immunoprecipitated with anti-FLAG mAb and 
treated similar to the cells in A, but using anti-FLAG, anti–
myosin IIA, anti-actin, and anti-WASp antibodies sequen-
tially for immunoblotting. The molecular masses of the 
proteins according to their position relative to molecular 
mass markers are shown in parentheses.JCB • VOLUME 173 • NUMBER 1 • 2006  128
other than WASp regulation. To assess WIP functionality in 
NK cells, RNAi was used to decrease WIP expression in NK 
cells (Fig. 7). Introduction of WIP siRNA to YTS/KIR2DL1 
cells caused a marked reduction of WIP expression and almost 
complete inhibition of NK cell cytotoxicity (Fig. 7, A and B). 
Comparatively, WASp RNAi in YTS/KIR2DL1 cells resulted 
in only a moderate decrease in cytotoxicity. Importantly, WIP 
RNAi eliminated the formation of the multiprotein complex. 
Gel fi  ltration analysis of WASp, actin, and myosin IIA from 
WIP RNAi-treated cells revealed that these proteins were 
eluted with the same partition coeffi  cients in both resting and 
activated cells, indicating that the complex was not assembled 
in these cells (Fig. 7 C).
Thus, WIP has a vital role in multiprotein complex forma-
tion and is indispensable for NK cell cytotoxic activity. More-
over, controlled assembly of the multiprotein complex as the 
result of NK cell signaling indicates the importance of the com-
plex in NK cell cytolytic activity.
Discussion
Actin rearrangements are vital for cell conjugation and immune 
synapse formation in NK and T cells. Formation of fi  lamentous 
actin rings at the immune synapse allows for fi  rm coupling of 
the lymphocyte with its target cell and ensures localized deliv-
ery of lytic granules (Stinchcombe et al., 2001; Vyas et al., 
2002). Cytoskeleton reorganization is required for sustained 
signaling in T cells (Valensin et al., 2002), and inhibition of 
  actin polymerization by cytochalasin D prevents NK cell cyto-
toxic activity (Orange et al., 2003). Thus, affecting the actin 
cytoskeleton itself or key regulatory proteins involved in its 
  polymerization may present a rapid mechanism for inhibiting 
cytotoxic activity.
We show that activation of NK cells by their target cells 
results in formation of a large ( 1.3 mD) multiprotein complex 
comprised of WIP, WASp, actin, and myosin IIA. These proteins 
polarize to the cell–cell contact site after NK cell activation 
Figure 7.  Effects of WIP RNAi on NK cell 
  cytotoxicity. (A) Vector-based RNAi was used 
to disrupt WIP or WASp expression. Decrease of 
protein expression was assessed by the immuno-
blotting of total cell lysates with anti-WIP or 
anti-WASp antibodies. Anti-ERK1/2 antibody 
was used to detect ERK1/2 and ensure equal 
loading of proteins. (B) Cytotoxic activity of 
untransfected YTS/KIR2DL1 cells or transfected 
with either WIP or WASp RNAi or empty vector. 
The percentage of 721.221 target cell lysis at 
different effector-to-target ratios is shown. Error 
bars represent SD. n    3. (C) Gel ﬁ  ltration 
  experiments. WIP RNAi-treated cells alone or 
mixed with 721.221 target cells for 10 min at 
37°C were lysed, and the lysates were applied 
to the Superose 6 column. Proteins from frac-
tions were visualized by immunoblotting to 
identify the main components of the complex 
(only relevant fractions are shown). The molec-
ular masses of the proteins according to their 
position relative to molecular mass markers are 
shown in parentheses. Kav values for proteins 
of interest were calculated based on elution 
volumes and ﬁ  tted to a calibration curve to es-
timate the size of complexes. Neither WASp 
nor actin, nor myosin IIA, changed their rela-
tive positions after NK cell stimulation.MULTIPROTEIN COMPLEX IN NK CELLS • KRZEWSKI ET AL. 129
(Fig. 4 and Fig. S1). Assembly and localization of this complex 
is affected by KIR inhibitory signaling (Fig. 1, A and C; and 
Fig. 4), indicating the functional signifi  cance of the complex 
for NK cell activity. The essential role of WIP in the formation 
of this complex and in cytotoxicity may be dependent on its 
phosphorylation by PKCθ (Figs. 5–7). WIP, which was origi-
nally identifi  ed as a protein interacting with WASp (Ramesh 
et al., 1997), was later shown to bind both monomeric and fi  la-
mentous actin, to retard WASp-mediated actin polymerization 
in vitro (Martinez-Quiles et al., 2001), and to have a variety of 
functions, many related to cell signaling and motility (Anton 
et al., 2002, 2003; Sasahara et al., 2002; Kinley et al., 2003; 
Kettner et al., 2004).
WIP immunoprecipitates from activated YTS cells con-
tain WASp, actin, and myosin IIA (Fig. 1, A and C; and Table I).
The presence of actin and WASp in WIP preparations is in 
agreement with previous studies (Ramesh et al., 1997;   Martinez-
Quiles et al., 2001). Actin association with WIP is independent 
of WASp, as indicated by the fact that a WIP mutant unable 
to interact with WASp interacts with actin (Fig. 5). However, 
this association is dependent on WIP, as the disruption of WIP 
expression inhibits multiprotein complex formation (Fig. 7 C). 
Actin binds to the NH2-terminal part of WIP (Martinez-Quiles 
et al., 2001), whereas WASp interacts with the WIP COOH-
terminal sequences (Ramesh et al., 1997; Anton et al., 1998), 
explaining the observed result. However, the decreased amount 
of actin in WIP∆460–503 immunoprecipitates suggests that 
WASp may contribute to actin recruitment, likely by binding 
additional actin monomers (Miki and Takenawa, 1998).
The presence of a class II myosin as the part of the mul-
tiprotein complex (Fig. 1 and Table I) has not been described 
previously. A WIP homologue from yeast, verprolin, has been 
demonstrated to bind class I myosin (Anderson et al., 1998; 
Geli et al., 2000). Although mammalian class I myosin func-
tion is still poorly understood, recent studies provide support for 
the role of another member of the myosin family, myosin IIA, 
in leukocyte activity (Swanson et al., 1999; Rey et al., 2002; 
Jacobelli et al., 2004; Bastian et al., 2005). WIP, as well as 
WIP∆460–503, immunoprecipitates from YTS cells contain my-
osin IIA, indicating an interaction between WIP and myosin IIA. 
This interaction could be direct, through actin, or through some 
other protein.
WIP and WASp from nonstimulated cells segregate as 
an  350–400 kD protein complex. Purifi  ed WASp and its ho-
mologue N-WASp were previously shown to behave as dimers 
or multimers (Carlier et al., 2000; Higgs and Pollard, 2000). 
WASp dimer, together with bound WIP, would create a hetero-
tetramer structure with a theoretical mass of  250–260 kD. 
Additionally, WASp is known to bind a plethora of adaptor and 
regulatory proteins (Orange et al., 2004), which could explain
why WIP and WASp are parts of an  400 kD complex. 
 Importantly, neither myosin IIA nor actin is observed in the frac-
tions containing WIP and WASp, demonstrating that the complex 
is not formed in nonactivated NK cells (Fig. 2 A). Activation 
of YTS cells results in the shift of a substantial portion of WIP 
and WASp to the high molecular mass fraction, accompanied 
by the occurrence of myosin IIA and actin in the same fraction 
(Fig. 2 B), indicating that the multiprotein complex is formed in 
response to NK cell stimulation. The main protein contributing 
to the mass of  1.3 mD is myosin II because class II myosins 
are composed of two heavy (171–244 kD) and four light 
(16–25 kD) chains, forming a heterohexamer (Sellers, 2000).
Activation of YTS cells by target cells causes association 
of actin and myosin IIA with WIP and WASp. The complex is 
formed after 3 min of activation, with the maximum actin and 
myosin IIA recruitment at 10 min (Fig. 1). The short time that 
the myosin IIA regulatory chain is present suggests that 
  myosin IIA is fully functional only for the short period required 
to fulfi  ll its task. However, the prolonged association of myosin 
IIA heavy chain with the complex (Fig. 1) may favor a quick re-
sponse to new stimuli, as short-term interaction would generate 
a delay required for full myosin IIA heterohexamer assembly. 
Because the role of myosin IIA in the complex is not clear yet, 
one speculation would be that myosin IIA moves along the actin 
cytoskeleton and transports WIP and WASp as “cargo” to places 
of dynamic actin assembly, i.e., the immune synapse. F-actin is a 
part of the complex (Fig. 1 E). In cytolytic conjugates, WIP and 
WASp polarize to the cell–cell contact site where myosin IIA 
and F-actin also accumulate (Fig. 4 and Fig. S1). After transloca-
tion to the cell–cell interface, WASp could stimulate the Arp2/3 
complex to create new actin branches (Higgs and Pollard, 2000), 
whereas WIP could stabilize newly formed actin fi  laments 
(Martinez-Quiles et al., 2001) to allow more fi  rm cell–cell 
coupling and   provide a rigid scaffold for the immune synapse.
Signaling-defi  cient KIR2DL1*250 provides support for a 
specifi  c role of KIR2DL1 in the inhibition of multiprotein com-
plex formation. Contrary to wild-type KIR2DL1, recognition of 
HLA-Cw6 on the surface of target cell by KIR2DL1*250 has 
no effect on complex formation, indicating that the complex is 
formed despite the recognition of MHC class I ligand (Fig. 1, 
C and D). Thus, KIR2DL1-mediated signaling can affect pro-
teins involved in actin cytoskeleton reorganization. Inhibitory 
signaling may affect the complex directly by dephosphorylat-
ing one or more of its components, or indirectly by targeting 
regulatory molecules (e.g., adaptors and kinases) upstream of 
WIP and WASp. Phosphorylation of KIR ITIMs results in the 
recruitment of SHP-1 and -2 phosphatases (Olcese et al., 1996), 
which may dephosphorylate Vav-1, thus preventing Cdc42 
  activation. At the least, a “trapping” mutant of SHP-1 binds 
Vav-1 (Stebbins et al., 2003). Because Cdc42 is required for 
WASp activation and myosin IIA activity (Vicente-Manzanares 
and Sanchez-Madrid, 2004), Vav-1 dephosphorylation by SHP-1
could affect complex functionality. The possibility that SHP-1 
and -2 dephosphorylate several of the regulatory components, 
as well as proteins of the multiprotein complex, needs to be 
carefully examined.
A specifi  c inhibitor for PKCθ effectively prevents WIP 
phosphorylation, showing that WIP is phosphorylated by PKCθ 
in NK cells (Fig. 6 C). This result, directly demonstrating WIP 
phosphorylation in vivo, supports previous indications of PKCθ 
involvement in WIP phosphorylation in T cells using WIP-
 specifi  c peptide antibodies (Sasahara et al., 2002). Interestingly, 
a low level of WIP phosphorylation was observed before NK cell
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at one site and undergo regulated phosphorylation at another 
site in response to cell stimulation. Ser488 of WIP was identi-
fi  ed as a WIP phosphorylation site using mutagenesis (Sasahara 
et al., 2002), and this residue may be a site of regulated WIP 
phosphorylation. Further direct identifi  cation of WIP phosphor-
ylation sites is an important next step.
Interestingly, no correlation between WIP phosphorylation 
level and WASp association is observed. WASp is associated 
with WIP even in resting cells (Figs. 2 and 4; unpublished data), 
suggesting constitutive interaction between WIP and WASp 
(in agreement with Ho et al. [2004]). WIP phosphorylation has 
been proposed to dissociate the WIP–WASp interaction in T cells 
  (Sasahara et al., 2002). However, an increase of WIP phosphory-
lation in response to NK cell activation is not accompanied by a 
change in the amount of WASp bound to WIP. Inhibition of WIP 
phosphorylation also does not affect the WIP–WASp interaction 
(Fig. 6). Although WIP phosphorylation does not regulate inter-
action of WIP and WASp in NK cells, the inhibition of PKCθ ac-
tivity, but not Src family kinases, and the consequent abrogation 
of WIP phosphorylation, prevents the recruitment of actin and 
myosin IIA to the complex. Additionally, inhibition of myosin II
activity by blebbistatin and ML-7 does not infl  uence interaction 
between any of the four proteins, indicating that myosin IIA
activity is not required for the assembly (Fig. 6 C). Ligation 
of KIR2DL1 by HLA-Cw6 results in the suppression of WIP 
phosphorylation and correlates with prevention of a multiprotein 
complex formation (Fig. 6 B and Fig. 1 C).
Disruption of WIP expression by RNAi leads to a nearly 
complete loss of cytotoxicity, supporting the unique role of WIP 
in NK cell activity. In contrast, WASp RNAi results in incom-
plete loss of cytotoxicity (Fig. 7), similar to that observed in 
WAS patients (Orange et al., 2002). Because actin cytoskeleton 
rearrangements are essential for lymphocyte activation (Miletic 
et al., 2003), the observed defects in NK cell cytotoxic activity 
are, at least in part, likely caused by faulty actin  polymerization. 
Alternatively, other proteins may be able to substitute for WASp 
function in activation of the Arp2/3 complex (Falet et  al., 
2002; Weaver et al., 2002). Depletion of WIP causes more 
profound effects. WIP regulates WASp activity (Martinez-
Quiles et al., 2001), is required for cortical actin network 
  organization (Anton et al., 2002), is essential for multiprotein 
complex formation, and appears to play a central role in NK 
cell cytotoxicity.
Materials and methods
Antibodies
Polyclonal anti-KIR2DL1 antibodies were generated using full-length 
KIR2DL1 protein. Other antibodies used include the following: anti-KIR 
mAb (EB6; Beckman Coulter), anti-WASp (US Biological), anti-WIP (a gift 
from R. Geha and N. Ramesh, Children’s Hospital Boston, Boston, MA), 
anti-ERK1/2 (Upstate Biotechnology) and MOPC-21 (isotype control), anti-
phosphotyrosine (PT66), anti–myosin IIA heavy chain, anti-FLAG (M2), 
anti-myosin regulatory light chain (MY-21), anti-actin, anti–rabbit IgG (RG-96), 
and anti–mouse IgG (all from Sigma-Aldrich). Alexa Fluor–conjugated 
reagents were obtained from Invitrogen.
Plasmids and construct generation
The FLAG-pMX vector was generated using pMX-IRES-GFP plasmid (a gift 
from T. Kitamura, University of Tokyo, Tokyo, Japan). Two DNA oligos 
  encoding the FLAG peptide sequence were inserted into pMX-IRES-GFP 
vector to generate FLAG-pMX-IRES-GFP plasmid. The full-length WIP and 
WIP∆460–503 cDNA were ampliﬁ   ed from pcDNA3-WIP vector (a gift 
from N. Ramesh). Both, WIP and WIP∆460–503 constructs were subse-
quently inserted into the FLAG-pMX-IRES-GFP vector. All constructs were 
veriﬁ  ed by DNA sequencing analysis.
WIP and WASp RNAi
Vector-based RNAi, targeting the G  G  A  G  G  T  T  T  C  C  T  G  T  G  C  C  T  T  C  T   sequence 
of WIP and the G  G  G  A  A  C  A  G  G  A  G  C  T  G  T  A  C  T  C  A  C   sequence of WASp, 
was used to generate WIP and WASp knockdown cell lines. Two DNA 
oligos designed to produce WIP or WASp siRNA hairpins were inserted 
into pBS-U6-RNAi-dual-CMV-GFP vector (a gift from X. Liu, Harvard Uni-
versity, Cambridge, MA; Sui et al., 2002; Tang et al., 2004). The con-
struct was veriﬁ  ed by DNA sequencing and introduced into YTS/KIR2DL1 
cells using Nucleofector I (Amaxa Biosystems). The GFP-positive cells were 
sorted using a MoFlo high performance cell sorter (DakoCytomation). WIP 
or WASp expression levels in each stable cell clone were examined by 
Western Blot. The clones with a substantial decrease of WIP or WASp 
expression levels were selected and sorted. At least six clones were ana-
lyzed and one representative clone was used for studies of WIP or WASp 
knockdown effects.
Cells, WIP, and WASp transfectants
Cells were maintained in RPMI 1640 medium supplemented with 10% 
FCS, L-glutamine, and 1.6 mg/ml genectin (Invitrogen) or 2 μg/ml puromy-
cin (Sigma-Aldrich). FLAG-WIP and FLAG-WIP∆460–503 constructs were 
transfected into the retrovirus-packaging Plat-E 293 Eco cell line (Morita 
et al., 2000). Retroviruses were used to infect tumor NK YTS/KIR2DL1 
or YTS/KIR2DL1*250 cell lines, as previously described (Cohen et al., 
1999). GFP-positive transfected cells were sorted using a MoFlo high per-
formance cell sorter.
Cell stimulation, Western blotting, immunoprecipitation, 
and silver staining
For antibody-mediated KIR2DL1 cross-linking, 4 × 10
6 YTS/KIR2DL1 cells 
were incubated with EB6-coated protein G magnetic beads (2.8 μm; 
Dynal) for 3, 10, or 30 min at 37°C in PBS supplemented with 2% FCS. 
For negative controls, 4 × 10
6 YTS/KIR2DL1 cells were incubated with 
MOPC21-coated protein G magnetic beads and 4 × 10
6 YTS or YTS/
KIR2DL1*250 cells were incubated with EB6-coated protein G magnetic 
beads for 3 min at 37°C in PBS/2% FCS. After stimulation, cells were mixed
with an equal volume of ice-cold 2× lysis buffer and lysed for 30 min 
at 4°C. Magnetic beads were isolated from the total cell lysates using a   
magnet (Dynal) and washed extensively with ice-cold lysis buffer (1% NP-40,
50 mM TRIS/HCl, pH 7.4, 150 mM NaCl, and 1 mM Na3VO4).
For cell mixing, 2 × 10
6 cells, either YTS/KIR2DL1/FLAG-WIP, YTS/
KIR2DL1-FLAG-WIP∆460–503, or YTS/KIR2DL1*250/FLAG-WIP, were 
mixed with 2 × 10
6 721.221 or 721.221/Cw6 cells in complete RPMI 
medium. Mixed cells were immediately transferred to a 37°C water bath 
and incubated for 3, 10, 30, or 60 min, followed by brief centrifugation 
and lysis in ice-cold lysis buffer for 30 min at 4°C. For time 0, cells were 
mixed and immediately lysed. Cleared cell lysates were incubated with 
anti-FLAG mAb coupled to protein G Sepharose beads (Sigma-Aldrich). 
Sepharose beads were pelleted by centrifugation (5,000 RPM for 2 min at 
4°C) and washed extensively with ice-cold lysis buffer.
In experiments involving anti-actin drugs, the following compounds 
were used: 20 and 50 μM latrunculin A or B, 1 μM jasplakinolide A, and 
0.5 μM swinholide A. YTS/KIR2DL1/FLAG-WIP cells were pretreated with 
anti-actin drugs or 0.1% DMSO (controls) for 30 min at 37°C, followed 
by mixing with 721.221 target cells for 10 min at 37°C. Cell lysates were 
immunoprecipitated with anti-FLAG antibody.
Immunoprecipitated proteins were resolved on 4–12% NuPage gels 
(Invitrogen) and either stained with a Silver Staining kit (GE Healthcare) or 
transferred to a PVDF membrane (Invitrogen). The membrane was blocked 
with 1% BSA in TBS with Tween-20, followed by incubation with a primary 
antibody. The membrane was then incubated with HRP-conjugated second-
ary antibodies, either anti–rabbit or anti–mouse, unless HRP-conjugated 
primary antibodies were used. Immunoblots were developed using ECL 
Western Blotting detection reagents (GE Healthcare).
[
32P]orthophosphate labeling and kinase inhibition
2 × 10
6 YTS/KIR2DL1/FLAG-WIP cells were labeled for 4 h at 37°C with 
[
32P]orthophosphate (0.2 mCi/ml, 285.6 Ci/mg; Perkin Elmer) in phosphate-
free RPMI 1640 media (CHEMICON International, Inc.) supplemented with 
10% phosphate-free FCS. Labeled cells were mixed with either 721.221 or 
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lysed, and immunoprecipitated with anti-FLAG antibody. Radiolabeled pro-
teins were visualized by autoradiography. Incorporated radioactivity was 
quantiﬁ  ed using SigmaGel software v1.0 (Jandel Scientiﬁ  c), normalized to 
phosphorylation, observed at time 0, and expressed as arbitrary units. In 
experiments involving kinase inhibitors, the following inhibitors were used: 
100 nM bisindolylmaleimide I, 100 μM PKCα,β pseudosubstrate inhibitor, 
100 μM PKCθ pseudosubstrate inhibitor, 2 μM casein kinase II inhibitor, 
1 μM PP2, 100 μM blebbistatin, and 5 μM ML-7 (all from Calbiochem). 
Labeled cells were treated with kinase inhibitors or 0.1% DMSO (control) 
for 30 min at 37°C, followed by mixing with 721.221 target cells for 
10 min at 37°C, cell lysis, and immunoprecipitation with anti-FLAG 
  antibody. Immunoprecipitated proteins were visualized by   autoradiography 
and subsequently blotted with the indicated antibodies.
51Cr release assay
YTS/KIR2DL1 cell cytotoxicity was evaluated by 
51Cr release assay as pre-
viously described (Orange et al., 2002).
Gel ﬁ  ltration
Gel ﬁ  ltration was performed on a Superose 6 column (106.5 ml; GE Health-
care) using a BioLogic Workstation (Bio-Rad Laboratories). Cleared cell ly-
sates from 2 × 10
7 YTS/KIR2DL1/FLAG-WIP or YTS/KIR2DL1/dsRNAWIP 
cells, either resting or stimulated with 721.221 (1:1 ratio), were applied to 
the Superose 6 column. Samples were eluted at 4°C with TBS and 1.25-ml 
fractions were collected. Proteins from each fraction were precipitated with 
10% TCA and the neighboring fractions (e.g., 1 + 2, 3 + 4, etc.) were 
pooled to reduce the number of samples for analysis. Precipitated proteins, 
which were transferred to PVDF membrane, were immunoblotted with anti–
myosin IIA, anti-FLAG, anti-WASp, or anti-actin antibodies.   Calibration 
curves were prepared by measuring the partition coefﬁ  cients (Kav) of mo-
lecular mass markers (GE Healthcare) and plotting them against log mo-
lecular mass. Kav values for proteins of interest were calculated based on 
elution volumes and were ﬁ  tted to the calibration curve. All partition coef-
ﬁ  cients were calculated using the following equation:
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where Ve = elution volume for the protein, Vo = void volume of column, 
and Vt = total volume of column.
Protein identiﬁ  cation by MS
YTS/KIR2DL1/FLAG-WIP cells were stimulated, lysed, and cleared, and 
cell lysates were immunoprecipitated with anti-FLAG mAbs and resolved 
on a 4–12% NuPage gel. Gels were stained with a Colloidal blue staining 
kit (Invitrogen), and individual protein bands were subsequently excised 
and digested with 12.5 ng/μl trypsin (Promega). Resultant protein samples 
were analyzed using a Finnigan LTQ linear ion trap mass spectrometer 
(Thermo Electron Corp). Ion trap spectra were obtained and MS data was 
analyzed using the Sequest Cluster with BioWorks software, which was 
supplied by the manufacturer. Certain peptides were further positively 
  identiﬁ  ed by MS peptide sequencing, which was facilitated through the 
use of the ProFound peptide mapping software (The Rockefeller University). 
MS experiments and analysis were performed in the proteomics facility of 
the Children’s Hospital of Philadelphia.
Cell conjugation and microscopy
YTS/KIR2DL1/FLAG-WIP cells were conjugated to either 721.221 or 
721.221/Cw6 cells at a 1:1 ratio for 10 min at 37°C in complete RPMI 
medium, followed by adherence to poly-L-lysine–coated slides (Sigma-
  Aldrich) for 15 min at 37°C. Next, the adherent cells were washed with 
PBS, ﬁ  xed, and permeabilized with Cytoﬁ  x/Cytoperm buffer (BD Biosci-
ences) supplemented with 0.1% Triton X-100. After blocking with 1% BSA, 
cells were stained with anti-WASp mAbs followed by Alexa Fluor 647–
  conjugated goat anti–mouse, anti–myosin IIA followed by Alexa Fluor 
405–conjugated goat anti–rabbit, and Cy3-cojnugated anti-FLAG mAb. 
Antibodies were used in the range of 1–20 μg/ml. F-actin was stained 
using Alexa Fluor 647–conjugated phalloidin. Cell conjugates were 
  visualized by a laser-scanning confocal microscope (LSM510 Axiovert 
100M; Carl Zeiss MicroImaging, Inc.). NK cells were identiﬁ  ed by GFP 
ﬂ  uorescence and positive anti-FLAG staining. The percentage values were 
determined by evaluation of 150–200 conjugates in randomly selected 
ﬁ  elds, in 3–4 separate experiments. The images were obtained using 
63× Plan-Apochromat objective and LSM510 software v. 3.2 (both Carl 
Zeiss MicroImaging, Inc.). Because of extensive photobleaching, the 
γ value of blue channel was increased from 1.0 to 1.4.
Online supplemental material
Fig. S1 shows the localization of F-actin and FLAG-WIP in YTS/KIR2DL1/
FLAG-WIP cells after the formation of cytolytic and noncytolytic conjugates 
with target cells. Online supplemental material is available at http://www.
jcb.org/cgi/content/full/jcb.200509076/DC1.
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